Fractyl Health, Inc. Common Stock (GUTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.99M
Last updated: Nov 17, 2026 at 11:05 AM ET
Fractyl Health, Inc. Common Stock (GUTS) Competitors
The companies most similar to Fractyl Health, Inc. Common Stock are Context Therapeutics (CNTX), Tscan Therapeutics (TCRX) and Citius Pharmaceuticals (CTXR). By market cap, Fractyl Health, Inc. Common Stock ranks 9th of the 13 companies on this page; Transcode Therapeutics (RNAZ) is the largest at $22.35M.
Peer Comparison
GUTS's ROIC of -245.8% is below the peer median of -150.1%, and its revenue growth of -57.1% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Fractyl Health, Inc. Common Stock (GUTS) | $11.99M | N/A | N/A | 0.0% | -245.8% | -57.1% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tscan Therapeutics Inc (TCRX) | $10.89M | N/A | 3.6x | 0.0% | -129.7% | -65.8% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| Chemomab Therapeutics Ltd DRC (CMMB) | $12.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| Akari Therapeutics PLC (AKTX) | $15.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Quantum BioPharma Ltd. (QNTM) | $10.35M | N/A | N/A | 0.0% | -150.1% | 0.0% | 0.00% |
| Transcode Therapeutics Inc (RNAZ) | $22.35M | N/A | N/A | 0.0% | -412.7% | 0.0% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tempest Therapeutics Inc (TPST) | $7.64M | N/A | N/A | 0.0% | -783.6% | 0.0% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD) | $15.74M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $13.64M | N/A | 2.8x | 0.0% | -150.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Fractyl Health, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Tscan Therapeutics Inc (TCRX) | Tscan Therapeutics Inc (TCRX) is a pioneering clinical-stage biotechnology company specializing in precision oncology through its proprietary T cell receptor... | TCRX competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
| Chemomab Therapeutics Ltd DRC (CMMB) | Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. | CMMB competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| Akari Therapeutics PLC (AKTX) | Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory... | AKTX competitors |
| Quantum BioPharma Ltd. (QNTM) | Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases. | QNTM competitors |
| Transcode Therapeutics Inc (RNAZ) | TransCode Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development and commercialization of drugs for the treatment of metastatic... | RNAZ competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| Tempest Therapeutics Inc (TPST) | Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated... | TPST competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| Tvardi Therapeutics, Inc. (TVRD) | Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet... | TVRD competitors |
Frequently Asked Questions About GUTS
Who are Fractyl Health, Inc. Common Stock's main competitors?
The companies most similar to Fractyl Health, Inc. Common Stock include Context Therapeutics (CNTX), Tscan Therapeutics (TCRX), Citius Pharmaceuticals (CTXR), Chemomab Therapeutics Ltd DRC (CMMB) and Cyclerion Therapeutics (CYCN), listed from the closest match.
Who is Fractyl Health, Inc. Common Stock's biggest competitor?
Transcode Therapeutics (RNAZ) is the largest of the similar companies at $22.35M; Context Therapeutics (CNTX) is the closest match by business profile, size, sector and industry.
How does GUTS stock compare with its competitors?
GUTS' net margin is 0.0% against a peer median of 0.0%.
Which of Fractyl Health, Inc. Common Stock's competitors pays a higher dividend?
Fractyl Health, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Fractyl Health, Inc. Common Stock bigger than its competitors?
No. Fractyl Health, Inc. Common Stock is 9th by market cap among the 13 companies on this page; the largest is Transcode Therapeutics (RNAZ) at $22.35M.
GUTS pages: Overview, Earnings, Forecast, Financials, Competitors